Despite previous reports of the wide variation in expression detected in relation to SNPs [43,44], in our study the MMP-3 5A/5A genotype was reflected in significantly higher levels of MMP-3 release in patients with breast cancer compared with the 5A/6A genotype, with the difference not quite reaching significance for the 6A/6A genotype group. This evidence concerns the gene MMP3 and breast cancer.